These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of antibody in in vitro stimulation of lymphocytes. Kapoor AK; Khan IU; Bhushan V Indian J Exp Biol; 1983 Nov; 21(11):583-4. PubMed ID: 6327508 [No Abstract] [Full Text] [Related]
12. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Sheridan JF; Aurelian L Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of protective mechanism against herpes simplex virus (HSV) infection in mice (author's transl)]. Nagafuchi S Fukuoka Igaku Zasshi; 1980 Jul; 71(7):353-64. PubMed ID: 6260612 [No Abstract] [Full Text] [Related]
15. The mechanism of recurrent infection by Herpesvirus hominis. Bierman SM Arch Dermatol; 1976 Oct; 112(10):1459-61. PubMed ID: 183607 [No Abstract] [Full Text] [Related]
16. [Antigen therapy of recurring herpes simplex with herpes simplex vaccine LUPIDON H and G]. Schneider J; Rohde B Z Haut Geschlechtskr; 1972 Dec; 47(24):973-80. PubMed ID: 4346378 [No Abstract] [Full Text] [Related]
17. [Infections due to herpes simplex virus, recurrent disease and problem of latency]. Terni M G Mal Infett Parassit; 1971 Jul; 23(7):433-67. PubMed ID: 4334706 [No Abstract] [Full Text] [Related]
18. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. Arvin AM; Pollard RB; Rasmussen LE; Merigan TC J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of recurrent Herpes simplex]. Söltz-Szöts J Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186 [No Abstract] [Full Text] [Related]